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Abstract 
 
Introduction: Prophylactic antimicrobial selection and administration for the prevention 
of surgical site infections in vascular surgery is a recommended best practice. Non-
adherence to published guidelines on the selection and administration of antimicrobials 
has been observed and may lead to reduced efficacy of antimicrobial prophylaxis. 
Methods: An observational, descriptive design was used to study clinician 
knowledge and behavior and included a retrospective patient record review and 
provider knowledge survey.  A clinical education intervention targeting providers 
responsible for the selection and administration of antimicrobial prophylaxis was 
conducted. A repeat patient record review and knowledge survey was completed 
following the education intervention. 
Results: The rate of timely administration of all antimicrobials increased from 69.2% to 
88.9% (χ2 = 0.5640, df = 1, p = 0.4526), and for vancomycin from 16.7% to 63.67% (χ2 = 
5.3158. df = 1, p = 0.0241). Rate of appropriate selection increased from 76.9% to 83.8% 
(χ2 = 0.5640, df = 1, p = 0.4526).  Knowledge and confidence among clinicians improved 
in some areas regarding the selection and administration of antimicrobial agents. 
Conclusion: This quality assessment and process improvement study demonstrated that 
with targeted educational experiences and supportive clinical decision-making tools, 
clinicians responsible for vascular surgery patients can improve their knowledge, 
selection and timely administration of prophylactic antimicrobials. Implementing these 
processes into existing pre-operative patient screening/assessment clinics and surgery 
scheduling mechanisms would hardwire this process setting the stage for clinical 
outcome trials. 
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Perioperative Antimicrobial Prophylaxis in Vascular Surgery: 
A Quality Assessment and Improvement Project 
Background 
Surgical site infections (SSI), defined by the Centers for Disease Control and 
Prevention (CDC) as “an infection that occurs after surgery in the area of the body where 
the surgery took place…” (CDC, 2016), are the second most common type of healthcare 
associated infection (Anderson et al., 2014; Culver, et al,1991).  Approximately 140,000 
vascular surgery procedures are performed annually in the United States (Calderwood et 
al, 2014; AHRQ-HCUPnet, 2016). Risk factors for vascular SSIs may be patient related, 
surgical (procedure) related, and/or environment related (Tatterton & Homer-
Vanniasinkam, 2011).  Patient factors that increase risk include: nasal colonization with 
methicillin sensitive staphylococcus aureus (MSSA) or methicillin resistant 
staphylococcus aureus (MRSA), end-stage renal disease, obesity, advanced age, smoking, 
and diabetes (Inui & Bandyk, 2015). Environmental factors that augment risk include the 
degree of operating room ventilation, environmental surface cleaning, surgical instrument 
and implant sterility, surgical attire, and sterile operative technique (Inui & Bandyk, 
2015). Vascular procedures that are open/infrainguinal (infra-aortic) and those with 
prosthetic implantation are associated with the highest infection rates, and highest 
morbidity, respectively (Tatterton & Homer-Vanniasinkam, 2011; Vogel, et al., 2010; 
Stone, et al., 2010; Ryan, Calligaro, Scharff, & Dogherty, 2004). 
Vascular surgery patients are at increased risk of developing surgery related 
infections (Tatterton & Homer-Vanniasinkam, 2011). When compared to overall SSI 
rates of 1-5%, reported by the Centers for Disease Control and Prevention’s National 
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Nosocomial Infections Surveillance Risk Category System, vascular surgery patients 
have SSI rates of 5-30% (Anderson et al., 2014; Calderwood et al, 2014; Culver, et al, 
1991; NNIS, 2004; Tatterton & Homer-Vanniasinkam, 2011; Stone, et al., 2010). The 
institutional standardized infection ration (SIR) for SSI occurrence for colon surgery 
(95% CI [0.949, 1.947]) is no different than national benchmarks (SIR =1) (Medicare, 
2019). For abdominal hysterectomy surgery institutional SIR for SSI occurrence (95% CI 
[0.009, 0.863]) are better than national benchmarks (SIR = 1) (Medicare, 2019). These 
are the only reported local SSI data by this institution. Local vascular surgery SSI rates 
are not readily published or systematic surveilled, however some vascular surgery 
attending physician receive a report on detected SSIs. 
 Patients who undergo vascular surgery have increased morbidity and mortality 
when they develop an SSI, vascular prosthetic graft infection (VPGI), or vascular access 
infections (Tatterton & Homer-Vanniasinkam, 2011). An increased risk of death 
following SSI has been described, with a relative risk (RR) of 2.2, 95% CI [1.1, 4.5] 
(Forbes & McLean, 2013). Mortality has been estimated as high as 13-58% when 
associated with vascular prosthetic graft infections (Young, Washer, & Malani, 2008).  
Antimicrobial therapy continues to be strongly recommended by the CDC, 
National Surgical Infection Prevention Project, Surgical Infection Society and Society for 
Healthcare Epidemiology of America (Page et al., 1993; Bratzler & Houck, 2004; 
Tatterton & Homer-Vanniasinkam, 2011; Bratzler, et al., 2013; Hsu, 2014). Current best 
practice includes the screening of patients preoperatively for the appropriate 
antimicrobial prophylaxis. It is recommended that vascular surgery patients receive 
weight-based cefazolin, a second-generation cephalosporin, unless the patient has a 
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serious life-threatening allergic reaction to cephalosporins, is colonized with MRSA 
and/or is scheduled to undergo an infra-aortic prosthetic implantation for which 
vancomycin is recommended. Deviation from the current guidelines for the 
administration of the appropriate preoperative prophylactic antimicrobial therapy has 
been observed (Zaidi, Tariq, & Breslin, 2009; Hawn et al., 2008; Weber et al., 2008; 
Dull, Baird, Dulac, & Fox, 2008; Tatterton & Homer-Vanniasinkam, 2011), does not 
meet current best practice guidelines (Bratzler et al, 2013) and should be evaluated, 
measured and improved upon. 
Review of Literature 
Databases utilized to identify pertinent literature included the Cumulative Index to 
Nursing and Allied Health (CINAHL) complete, Ovid Medline, and PubMed Clinical 
Queries. Keywords and Medical Subject Headings (MeSH) included: surgical wound 
infection/*prevention & control, surgical wound infection/*microbiology, vascular 
surgical procedures/*adverse effects, drug administration schedule, antibiotic 
prophylaxis/*methods, anti-bacterial agents/*administration & dosage, anti-bacterial 
agents/*therapeutic use, surgical wound infection/epidemiology, anti-bacterial 
agents/*therapeutic use, vancomycin/*therapeutic use, vancomycin/administration and 
dosage, and practice patterns. Practical screens were used to focus the review and 
included publication dates of 2000-2017 and English language, peer reviewed articles. 
Landmark articles were included despite publication date limiters when five or more 
articles referenced the work, this totaled one landmark study by Classen (1992). 
Methodological screens applied included national and international guidelines, systematic 
review or meta-analyses of randomized controlled trials, randomized controlled trials, 
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case control studies, cohort studies and descriptive and qualitative studies. Articles 
selected for review were organized into patient / economic significance and scientific 
underpinnings categories. A table summarizing the articles reviewed can be found in the 
appendices (Appendix A) 
Patient & Economic Significance 
The impact of SSIs in the vascular surgery patient has a human cost as well as a 
financial cost (de Lissovoy et al., 2009; Gagliardi, Fenech, Eskicioglu, Nathens, & 
McLeod, 2009; Stone et al., 2010; Salkind & Rao, 2011; Dua et al., 2014). A patient who 
develops an SSI, compared to a patient who does not, experiences increased pain, 
undergoes secondary operations, spends an average of 17 days more hospitalized, has a 
two-fold chance of mortality, and is five times more likely to be re-admitted to the 
hospital (Tatterton & Homer-Vanniasinkam, 2011).  
The financial cost associated with infections in vascular surgery patients can be 
extrapolated from the above listed patient (human) costs and aggregate data on the cost of 
SSIs across all surgical services. In 2014, the Society for Healthcare Epidemiology of 
America reported the estimated annual cost associated with the development of an SSI 
ranges from $3.5 billion to $10 billion (Anderson et al., 2014). While estimates directly 
reflect the increased cost associated with vascular surgery patients, Engemann et al. 
(2003) found that surgery patients with a MRSA SSI had an additional cost of $40,000 
per hospital stay compared to those with MSSA SSIs. 
Infection is the most common complication associated with vascular surgery 
(Tatterton & Homer-Vanniasinkam, 2011). Clinicians caring for these patients have a 
responsibility to design and implement systems based care models to meet guideline 
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recommendations in an effort to maximize adherence to best practices (van der Slegt, et 
al. 2013; Anderson et al., 2014; Waits et al., 2014; Sutherland, et al., 2014). 
Scientific Underpinnings 
Gram-positive microorganisms make up approximately 80% of vascular SSIs, 
most commonly identified as staphylococcus aureus and coagulase-negative 
staphylococci (Tatterton & Homer-Vanniasinkam, 2011). Gram-negative species are also 
found, yet to a lesser degree (20%), and include Escherichia coli, Pseudomonas 
aeruginosa, and Klebsiella pneumoniae (Tatterton & Homer-Vanniasinkam, 2011). 
Cefazolin, a fourth-generation cephalosporin, continues to be the most recommended 
antimicrobial agent, due to its gram-positive microbial coverage, low cost, with gram 
negative coverage which includes Escherichia coli and Klebsiella pneumoniae (Bratzler 
et al., 2013). When infrainguinal prosthetic implantation is anticipated in patients with 
known MRSA colonization or in patients with a true cephalosporin allergy, antibiotics 
such as vancomycin (a glycopeptide) or daptomycin (a cyclic lipopeptide) are 
recommended to be added or used as an alternative, respectively (Bratzler et al., 2013).  
These recommendations come from the 2013 American Society of Health-System 
Pharmacists report on the clinical practice guidelines for antimicrobial prophylaxis in 
surgery (Bratzler et al., 2013). 
The efficacy of timely prophylactic antimicrobial administration was described in 
a landmark report by Classen et al. (1992). This report prompted the adoption of 
widespread guidelines for well-timed prophylactic use of antimicrobial agents to prevent 
surgery associated infections. Since then, there have been numerous reports that correlate, 
and a few that refute, the timing of antimicrobial agent administration to the occurrence 
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of SSIs (Hawn, Itani, Gray, Vick, Henderson, & Houston, 2008; Weber et al, 2008; 
Steinberg et al, 2009; Stone, et al., 2010; Fry, 2006; Anderson, et al, 2014; Dua et al, 
2014; Stone et al, 2015).  
The evidence that questions the importance of timing of administration is 
marginal. Two reports by Hawn and colleagues (Hawn et al., 2008; Hawn et al., 2013) 
challenge the importance of timing. However, methodological weaknesses can be 
identified in these works. In these reports, when two antimicrobial agents were used, only 
the one administered “closest to, but before incision” was recorded for timing of 
antibiotic (Hawn et al., 2013, pg. 650). The limitation of this approach centers on the 
selection for and reporting of an independent variable (timing of antibiotic) that excludes 
the considerable circumstances where more than one agent was used, thus overestimating 
the occurrence of timely administration. This is significant given that one agent can be 
administered rapidly (e.g., cefazolin) and the other often requires up to 60-120 minutes to 
be administered (e.g., vancomycin).  
Despite any perceived controversy surrounding the timing of antimicrobial 
administration, current guidelines continue to recommend their timely routine use in 
high-risk procedures (Bratzler et al., 2013).  However, despite these recommendations 
reports conclude that the timely administration of antimicrobial prophylaxis occurs only 
50-80% of the time (Hawn et al., 2008; Weber et al., 2008; Dull, et al., 2008; Tatterton & 
Homer-Vanniasinkam, 2011), potentially resulting in sub-therapeutic antimicrobial tissue 
concentrations. In patients at high risk for developing an SSI, such as those receiving 
implanted graft material or with known MRSA colonization, low adherence to 
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antimicrobial guidelines have been shown to increase the occurrence of SSI (Classen, 
1992; Garey et al., 2006). 
Purpose Statement 
The purpose of this project was to conduct a systematic analysis of current 
practice and improve upon the process of selection and timely administration of 
vancomycin for antimicrobial prophylaxis in the adult vascular surgery population.  Pre-
intervention assessment will identify the current state of vancomycin selection and 
administration and knowledge gaps among surgical and anesthesia clinicians caring for 
vascular surgery patients.  Process improvement interventions composed of clinical 
education and decision support tools for clinicians who select (order) and administer the 
antimicrobial agents were implemented following the initial assessment. The aim was to 
improve adherence to established standards of practice and maximize the effectiveness of 
preoperative antimicrobial prophylaxis. Specific study questions included: 
(1) Will an educational program about recommended practice for the selection 
and administration of prophylactic antimicrobial agents in vascular surgery 
improve appropriate selection (agent and dosage) of antimicrobial 
prophylaxis?  
(2) Will an educational program about recommended practice for the selection 
and administration of prophylactic antimicrobial agents in vascular surgery 
improve timely administration (prior to surgical incision) of antimicrobial 
prophylaxis?  
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(3) Will an educational program about recommended practices for the selection 
and administration of prophylactic antimicrobial agents in vascular surgery 
improve clinician knowledge?  
(4) Will an educational program about recommended practice for the selection 
and administration of prophylactic antimicrobial agents in vascular surgery 
improve clinician confidence?  
Method 
 An observational, descriptive design was employed using retrospective record 
review and pre-/post-intervention clinician knowledge survey. One-group pretest-posttest 
and a two-group pretest-posttest methods were used to measure the knowledge, skill, and 
attitudes of perioperative clinicians about the prevention of nosocomial infection before 
and following the intervention. The one-group pretest-posttest data set was made up of a 
subset of clinicians that were identical before and after the intervention, this group was 
composed of the vascular surgery attending physicians and fellows. This subset is 
ultimately responsible for the selection and ordering of prophylactic antimicrobial agents. 
The two-group pretest-posttest data set was made up of all surgical and anesthesia 
clinicians before and after the intervention, this was not an identical group of participants, 
although there was some overlap.  
The pretest-posttest clinician surveys were developed using key information from 
the literature review. Survey questions were written to assess the knowledge of clinicians 
required for determining the type and timing of prophylactic antimicrobial therapy in 
vascular surgery patients and were derived from published guidelines (Page et al., 1993; 
Bratzler & Houck, 2004; Tatterton & Homer-Vanniasinkam, 2011; Bratzler, et al., 2013; 
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Hsu, 2014). Additional survey questions were written to assess clinician attitudes about 
best practices and their confidence in adhering to them.  
 The effectiveness of this improvement process was assessed by comparing 
guideline adherence rates before and after the interventions. A clinician education plan 
was delivered using current best practice guidelines derived from the review of the 
literature. This included a slide show presentation delivered to the vascular surgery team 
during their grand rounds meeting (Appendix B). Anesthesiology personnel were 
provided with the same information in a printed form accompanied with a one to one 
tutorial in the perioperative setting. Learning objectives of the educational intervention 
included understanding the importance of selection and administration timing of 
antimicrobial prophylaxis as well as recognition of current barriers to adherence to best 
practices. Secondary learning objectives included the incidence of surgical site infections 
in vascular surgery, the microorganisms responsible for SSIs, as well as risk factors that 
impact SSIs in vascular surgery. Throughout and for one month after the educational 
intervention, dedicated time was spent in the perioperative environment with both 
anesthesiology and surgical team members to support clinical decision making. In person 
support was provided 2-3 days a week between September and November to reinforce the 
educational program’s learning objectives.  
Following the implementation of a curriculum aimed at improving peri-operative 
clinician’s knowledge, skill, and attitudes about prescribing and administering 
antimicrobial prophylactics in vascular surgery, repeat retrospective record review and 
post-test surveys were performed. Variables of interest included the selection and 
administration timing of vancomycin in patients with a history of penicillin allergy, 
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incision prior to completed vancomycin administration, and planned infra-aortic 
prosthetic graft implantation in a patient with known MRSA colonization. Timely 
administration was determined by analyzing the time of initiation of each antimicrobial 
administered compared to the time of surgical incision. Timely administration was 
considered achieved when non-vancomycin agents were initiated five minutes prior to 
incision, timely vancomycin administration was considered achieved if initiated 60min 
prior to surgical incision. These variables were retrospectively evaluated in 76 cases of 
antimicrobial administration, 39 prior to project implementation and 37 afterwards. 
Setting/Population 
 Conducted at a mid-western United States tertiary academic urban hospital, this 
study focused on patients scheduled for vascular surgery who were aged 18 years or 
older. Clinicians whose practice was analyzed included attending vascular surgeons, 
vascular surgery fellows, vascular surgery residents, general surgery residents, attending 
anesthesiologist, nurse anesthetists, and anesthesiology residents. 
Sample 
Two separate samples were targeted by this project. A patient sample set and a 
clinician sample set. The patient sample set was comprised of a convenience sample of 
those scheduled for vascular surgery during periods of time during the months of 
February 2018 and October 2018. Patients were excluded from evaluations if they were 
less than 18 years old or if they did not receive antimicrobial prophylaxis. The patient 
sample set was used to gain information about which antimicrobial agent was selected 
and the timing of its administration in relation to surgical incision time. 
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The clinician sample set was composed of clinicians with backgrounds in 
anesthesiology and surgery. The clinician sample set was divided into two sub-groups 
and underwent a one-group and two-group comparison (see Table 1). Due to the 
unpredictable nature of clinician coverage and the variability of clinical assignments, it 
was not possible to acquire a perfectly matched (identical) clinician sample. Inclusion 
criteria for clinicians included the cadre of anesthesiology (attending anesthesiologists, 
certified registered nurse anesthetists, and anesthesiology residents) and surgery 
specialists (vascular surgery attending physicians, vascular surgery fellows, and vascular 
surgery residents) that care for vascular surgery patients having various levels of 
experience.  
Table 1: Clinician Sample Breakdown 
 Two-Group  
Clinician Sample 
One-Group*  
Clinician Sample 
Clinician 
Pre 
Survey 
n 
Post 
Survey 
n 
Pre 
Survey 
n 
Post 
Survey 
n 
Surgeon Attending 6 6 6 6 
Surgeon Fellow 4 4 4 4 
Surgeon Resident 4 4 4 4 
Anesthesiologist 
Attending 
9 6  
Nurse Anesthetist 
(CRNA) 
7 7 
Anesthesiology Resident 2 2 
Total n = 32 n = 29 N = 14 
*Indicates identical group of pre- & post- survey respondents. This group holds 
primary responsibility for prophylactic antimicrobial medication ordering. 
 
The one-group sub-set comparison was conducted on those with the role of 
vascular surgeon. These individuals were made up of vascular surgery attending 
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physicians, vascular surgery fellows, and vascular surgery residents. This group of 
individuals have the primary responsibility of selection and ordering of surgical 
antimicrobial prophylaxis. This group was identical in the pre and post evaluations, thus 
permitting a one-group comparative analysis 
A two-group comparison was completed for the entire pre- and post-intervention 
survey clinician sample sets. This group was composed of a mix of same individuals and 
unique individuals, necessitating a two-group analysis.  
Data Collection 
 Collection of patient and case specific data (Appendix C) was conducted using 
electronic medical record (EMR) review. During the course of this project there was an 
institutional overhaul of the EMR systems, thus both MetaVision (iMDsoft 2018) and 
EPIC© (EPIC systems corporation, Verona, WI, 2018) EMRs (post-intervention) were 
utilized. A fifteen-question knowledge, skill, and attitude survey (Appendix D) were 
utilized to query clinicians before and after the educational intervention. The surveys 
were conducted face to face by a single researcher on an individual basis in the 
perioperative areas. Post intervention surveys were performed approximately 2-3 weeks 
after the educational series.   
Data Analysis 
 Descriptive statistics, cross tabulation and Chi-square were used to describe the 
observed characteristics in the subjects analyzed before and after the educational 
intervention. Wilcoxon rank sum test was performed to assess test assumptions, for non-
normally distributed results, Wilcoxon signed rank analysis was performed. Statistical 
significance was set at 0.05 for statistical difference.  
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Results 
 Patient Sample Demographics: The pre-intervention patient sample (n = 39) 
included individuals aged 38 to 90 years old compared to post-intervention patient 
sample (n = 37) aged 19-78 years old. Age mean (m) and standard deviation (SD) for 
both pre- and post- samples were m = 67.6 (SD = 12.4) and m = 59.4 (SD 14.0), 
respectively.  
Appropriate Antimicrobial Selection: In the pre-intervention patient sample 
there were no incidences of true life threatening allergies to cephalosporins. In the post-
intervention patient sample, there were 4 cases of true life threatening cephalosporin 
allergy, in three of these four cases (75%) vancomycin was selected.  
There were no cases (pre or post) of patients with a history of MRSA positive 
microbiological studies undergoing infra-aortic prosthetic graft implantation (another 
indication for vancomycin).  
Clinician selection of the appropriate antimicrobial agent was performed 30 out of 
39 cases, a rate of 76.9%, in the pre-intervention patient sample compared to 31 out of 37 
cases, a rate of 83.8%, in the post-intervention group (χ2 = 0.5640, df = 1, p = 0.4526). 
Appropriate weight-based dosage of selected antimicrobial occurred at 35 out of 39 
cases, a rate of 89.7%, in the pre-intervention group compared to 36 out of 37 cases, a 
rate of 97.3%, in the post-intervention group (χ2 = 1.7654, df = 1, p = 0.1843). While not 
statistically significant there is clinical significance in the selection of the proper 
antimicrobial agent and dosage for any specific patient. 
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Timely Administration of Antimicrobial: Administration of antimicrobials 
(including vancomycin) prior to incision (i.e. timely administration) was achieved 27 out 
of 39 times (69.2%) in the pre-intervention group compared to 32 out of 36 times 
(88.9%) in the post-intervention group (χ2 = 4.3114, df = 1. p = 0.0379).  
In the pre-intervention group, completed vancomycin administration occurred 
prior to incision 2 out of the 12 times (16.7%) when vancomycin was selected for use. In 
the post-intervention group, completed vancomycin administration occurred prior to 
incision 7 out of the 11 times (63.6%) when vancomycin was selected for use. Chi square 
analysis of these results (χ2 = 5.3158, df =1, p = 0.0241) suggests a statistically significant 
improvement in the timely administration of vancomycin in the post-intervention group. 
 Clinician Knowledge: A subgroup analysis (one-group pre/post-test) was 
performed using Wilcoxon signed rank test on those clinicians who currently have the 
responsibility for ordering the antimicrobial prophylactic, namely the vascular surgery 
attending physicians and their vascular surgery fellows. In one (Q6) of the three questions 
targeting clinician knowledge (Q6*, S = -14.5, p = 0.0547) a difference approaching 
statistical significance was noted. However when looking at all clinicians (two-group 
analysis), two (Q4 & Q8) of the three questions demonstrated a significant improvement 
in clinician knowledge following the intervention (Q4, χ2 = 4.1112, df =1, p = 0.0465;. 
Q8, χ2 = 5.6509, df = 1, p = 0.0177). (see table 2). 
 Clinician Confidence: One survey question was designed to assess clinician 
confidence in selecting the appropriate antimicrobial for surgical prophylaxis. Due to the 
non-normal distribution that was observed between the pre- and post- intervention 
surveys, non-parametric testing was performed. Chi square analysis applied to the entire 
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pre- and post- survey groups (two-group pre/post-test) found statistically significant 
differences in three specific questions. One such question targeted clinician confidence 
(Q3, χ2 3.9936, df = 1, p = 0.0465), This question also demonstrated statistical 
significance in the sub-group analysis, i.e. one-group pre/post, (χ2 = 3.8774, df = 1, p = 
0.0325) (see Table 2).  
Table 2 
 
Q# Survey Question Two-Group 
(p-value) 
One-Group 
(p-value) 
1 Antimicrobial prophylaxis for patients undergoing open vascular 
surgery is consistent with best practice. 
0.2511 1.0000 
2 Antimicrobial prophylaxis does not contribute to reductions in 
vascular surgical site infection. 
0.2718 0.1875 
3 I am confident in selecting the correct antimicrobial prophylaxis 
for vascular surgery. 
0.0465* 0.0325* 
4 I am able to identify a serious adverse reaction to PCN or 
cephalosporin. 
0.0501* 0.4375 
5 I am able to identify whether or not a prosthetic graft will be 
implanted prior to surgery. 
0.8518 0.4375 
6 I am able to identify whether or not a patient has a history of 
MRSA/MSSA colonization. 
0.1352 0.0547 
7 I am able to identify whether or not a patient has increased risk 
for MRSA/MSSA colonization. 
 
0.2866 1.0000 
8 The institution where I practice is considered to have a high 
prevalence of MRSA/MSSA. 
 
0.0177* 0.1563 
9 It is best practice to administer the antimicrobial prophylaxis 
prior to surgical incision. 
 
0.8215 0.3750 
10 Patients with known MRSA/MSSA colonization should always 
receive vancomycin antimicrobial prophylaxis (if not allergic to 
vancomycin). 
 
0.6869 0.1484 
11 Patients scheduled for infra-inguinal prosthetic graft implantation 
should receive vancomycin antimicrobial prophylaxis (if not 
allergic to vancomycin). 
 
0.3654 0.4922 
12 Patients with serious adverse reactions to 
penicillin/cephalosporins should receive vancomycin 
antimicrobial prophylaxis (if not allergic to vancomycin). 
 
0.1505 0.1719 
13 If a patient has serious allergic reactions to cephalosporins AND 
vancomycin, I am confident in determining the best antimicrobial 
prophylaxis for vascular surgery procedures. 
 
0.0658 1.0000 
14 Overall, our antimicrobial prophylaxis selection is adherent to 
current clinical guidelines for vascular surgery. 
0.7549 0.7500 
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Q# Survey Question Two-Group 
(p-value) 
One-Group 
(p-value) 
15 Overall, antimicrobial prophylaxis administration is adherent to 
current clinical guidelines for vascular surgery. 
 
0.0765 0.3750 
 
Discussion 
 Appropriate Antimicrobial Selection: Potential clinical significance was also 
identified by the reduction of both inappropriately selected antimicrobial agent and 
inappropriate weight-based dosage of selected antimicrobial agent. 
Timely Administration of Antimicrobial: Findings from this quality/process 
improvement study of a midwestern academic vascular surgery service division indicates 
that there was a statistically significant reduction in inappropriately administered 
vancomycin following a clinician education intervention.   
 Clinician Knowledge: Improvement in clinician knowledge was noted in their 
identification of serious, life-threatening allergic reactions to penicillins/cephalosporins, 
as well as, institutional MRSA/MSSA prevalence rates. 
 Clinician Confidence: Survey data suggest that among all clinicians surveyed 
there was a statistically significant improvement in clinician confidence in selecting the 
correct antimicrobial prophylactic for vascular surgery.  
Limitations  
 Observing approximately 40 sequential pre- and post-intervention vascular 
surgery cases provided 12 and 11 vancomycin cases respectively for analysis. This small 
sample size lacks statistical power. Vancomycin was selected about 30% of the time 
when an antimicrobial prophylactic agent was indicated. This rate was observed for both 
pre- and post-intervention groups. This patient sample size was set by the time allocated 
to perform data collection and an estimation of frequency of surgical cases to be 
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evaluated. The frequency of vancomycin selection and administration was 
underestimated. Clinician samples sets were not controlled for with exception of the 
vascular surgeon subgroup, control of all clinician’s studies would have permitted one-
group parametric testing of all survey data. 
 Vancomycin is strongly indicated for vascular surgery patients in two instances 
(true life-threatening cephalosporin allergy and infra-aortic prosthetic graft implantation 
in patients with MRSA colonization). These two scenarios were not observed in both 
sample sets (pre & post) thus impairing the ability of this study to report on the effects of 
the intervention with respect to these two scenarios. 
 During the implementation of this quality assessment and improvement process 
the medical center where the data was being collected underwent an overhaul of their 
electronic health record systems. Due to this there were some differences in the manner 
by which some data points were recorded and ultimately measured. Although no obvious 
omissions or incorrect interpretations are suspected, they cannot be completely ruled out 
due to the possibility of user error with the implementation of a new software application. 
 Local institutional baseline SSI data for vascular surgery was not available thus 
only general assumptions about the state of SSI incidence in this specific population can 
only be assumed by evidence from studies in this field. 
  This study was also vulnerable to the Hawthorne effect as clinician participants 
were aware of the educational intervention they had participated in. To manage any 
instrumental threats, the pre/post tests were identical. There are no obvious regression 
threats as the population targeted is based on contact with the vascular surgery patient 
population alone. The one-group test for clinician knowledge and confidence was also a 
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small sample size, however was specific to the current paradigm for prescribing of pre-
operative antimicrobial prophylaxis (is the purview of this subgroup). Those outside of 
this vascular surgery subset currently hold more of a supportive role on this variable. 
Implications for Practice and Recommendations for Future Research 
 Practice implications identified by this project include the observed failure rate of 
timely vancomycin administration, a failure rate that persists despite an effective 
intervention. It is encouraging that a positive impact was observed, however there is still 
great need for practice change to reduce or eliminate this ongoing failure of timely 
administration of vancomycin. Also identified by the implementation of this project were 
challenges in SSI surveillance in the vascular surgery population. How SSI surveillance 
is routinely performed needs to further assessed, redesigned and implemented in an effort 
to evaluate the efficacy of and degree of impact on patient centered outcome 
interventions such as this clinical scholarship project. 
 The ability of education and clinical support tools to improve selection and timely 
administration of pre-operative antimicrobial prophylactic agents was suggested by this 
project. While the overall incidence of vancomycin selection did not change between 
groups, there was a reduction in both the number of inappropriately selected agents 
(vancomycin was selected less frequently) and inappropriately chosen doses of 
vancomycin. This has the potential to enhance the clinical effectiveness of vancomycin 
(when selected) to prevent a surgical site infection due to increased likelihood of 
achieving levels above the minimal inhibitory plasma and tissue concentrations.  
 Furthermore, this process improvement study demonstrates that timely clinical 
decision support resources, delivered at the point of decision-making, may improve 
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processes to perpetuate appropriate clinician decision making. A key implication for 
clinical practice is to hardwire this process, this is the likely next step for this project. 
Specifically, to leverage pre-operative patient screening and surgery scheduling practices 
to select and time the administration of pre-operative antimicrobial prophylaxis. The 
overhaul of the electronic health record system at this institution creates the opportunity 
to further develop screening tools that support clinicians in the selection and timely 
administration of prophylactic antimicrobials. 
 Following further development and hardwiring of processes to support 
prophylactic antimicrobial decision-making, future research should focus on the ability of 
such process improvement activities to impact the patient centered outcomes i.e., rate of 
surgical site infections. Potentially answering the following question “Can process 
improvement strategies aimed at improving the selection and timely administration of 
antimicrobial prophylaxis reduce surgical site infections in the vascular surgery 
population?”. 
Conclusions 
 This quality assessment and process improvement study demonstrated that with 
targeted educational experiences and supportive clinical decision-making tools, clinicians 
responsible for vascular surgery patients can improve their knowledge, confidence, and 
ability to select and timely administer antimicrobial prophylactic agents. Routine SSI 
surveillance is needed in this patient population prior to future outcome studies. 
Implementing these processes into existing pre-operative patient screening/assessment 
clinics and surgery scheduling mechanisms would hardwire this process setting the stage 
for clinical outcome trials. 
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Appendix A 
Evidence Table 
# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
1 Classen 1992 II* 
 
Randomized 
controlled Trial 
2847 patients  
 
Single center 
 
Across all lines of 
surgical services 
0.6% SSI rate in those 
who received 
antimicrobial 
preoperatively 
 
3.3% SSI rate in those 
who received 
antimicrobial 
postoperatively 
 
Those who received 
antimicrobial 1-2hrs prior 
to surgery had fewer 
(P<0.001) SSIs 
Exclusion of 
patients admitted 
>48hr prior to 
surgery (an 
important subset) 
 
Single center 
2 Engemann 2003 IV*  
Cohort Study 
Patients 
undergoing 
surgery with SSI 
surveillance 
 
N = 479 
 
Control group  
MRSA resistance is 
independently associated 
with increased mortality  
 
MRSA resistance is 
independently associated 
with hospital expense / 
charges 
Different types of 
antimicrobial 
therapy was not 
examined. 
 
Possible 
underestimation of 
cost due to 
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# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
MRSA group 
MSSA group 
potential for 
outpatient 
treatment not 
captured 
3 Fry 2006 V* 
Retrospective 
analysis 
Randomized  
Multi center 
(national CMS SIP 
database) 
 
788 randomly 
selected cases to 
establish baseline 
Poor compliance with 
timely administration, 
56% compliance 
 
Good performance on 
antimicrobial selection, 
97% correctly selected 
 
Poor compliance with 
discontinuing therapy 
<24hrs, 41% compliant 
Detailed patient 
population not 
reported 
 
Retrospective 
Variable data 
reporting accuracy 
across clinical sites 
(i..e database 
metrics) 
4 Garey 2006 III* 
Prospective non-
randomized 
Patients 
undergoing 
coronary bypass 
grafting or valve 
replacement 
surgery 06/2002-
06/2005. 
 
SSI rates were lowest in 
those receiving 
vancomycin between 16-
60min before surgical 
incision compared to the 
other four time 
groupings (3.4% vs. 
26.7%, 7.7%, 6.9%, and 
Single center 
 
Non-randomized 
 
No control group 
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# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
Five groups 
assigned based on 
timing of 
vancomycin 
dosing prior to 
surgical incision 
N = 2048 
7.8%) 
    68% male, 53% 
Caucasian. 
  
5 Dull 2008 QA/QI report 
 
Exemplar of 
successful 
implementation 
SCIP adherence at 
2 acute care 
hospitals in MI 
 
SCIP 1 = 64% to 90% 
SCIP 2 = 95% to 93% 
SCIP 3 = 60% to 95% 
 
General trend toward 
improved adherence 
Not scientific 
 
SCIP has fallen out 
of favor 
6 Hawn 2008 IV* 
retrospect 
cohort 
 
VA-elective 
Procedures 
 
N=9,195 
 
Mostly male 
Timely admin occurred 
86.4%  
 
Untimely SSI = OR 1.29, 
95%CI 0.99, 1.67 
 
Not all vascular 
surgery patients.  
 
VA pop. not 
representative (not 
generalizable) 
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# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
  
NSQIP used for 
outcome (limited to 
NSQIP collected 
information) 
7 Weber 2008 IV* 
Prospect 
Observe 
cohort 
Consecutive 
enrollment of 
visceral,  
Vascular, and  
Trauma sx 
 
01/2000-12/2001 
 
3836 cases 
 
50.7% male 
49.3% female 
 
15.3% vasc cases 
49% of the time anti- 
Biotic was admin  
Within the final 30min 
prior to incision 
 
Increased odds of SSI if  
Antibiotic admin <30 min 
prior. 
OR 1.95; 95%CI 1.4-2.8 
 
Admin 59-30min prior to 
incision is more effective 
than during last 30min 
Not RCT 
 
Post-discharge 
Monitoring not 
standardized 
 
Optimal timing not 
generalizable to all 
Antibiotic agents 
    
8 De Lissovoy 2009 IV* 
Retrospective 
analysis  
Data from 1054 
hospitals in 37 
states (accounting 
for ~90% of US 
Average increase in cost 
associated with SSI = 
$20,842 
 
Use of 
administrative data 
can be imprecise. 
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# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
hospital 
discharges) 
 
Surgical Subsets: 
Neuro, 
cardiovascular, 
colorectal, GI, 
OB/GYN, Ortho 
406,730 additional 
hospital days ($900 
million when 
extrapolated. 
 
91,613 readmissions 
leading to additional 
521,933 days of care 
($700 million when 
extrapolated) 
 
 
9 
 
Gagliardi 
 
2009 
 
Scoping Review 
of the Literature 
 
 
19 of 192 studies 
reviewed 
 
MEDLINE 
COCHRANE 
1996-2007 
 
7 = antibx use 
12 = adherence 
 
 
Factors that influence 
practice: 
-individual knowledge,  
Attitudes, beliefs & 
practices, institutional 
support 
 
Favor multi-disciplinary 
pathways, computerized 
order sets, and 
individualized 
performance data for QI 
strategies 
 
Limited data (not 
comprehensive) 
 
Not scientific, 
although very 
systematic 
 
Not delineated by 
type of surgery 
 
No control (case 
control) for 
intervention (no 
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# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
matching by patient 
or type of surgery) 
10 Steinburg 2009 IV* 
 
Prospective  
Cohort,  
 
multi-center 
4472 surgical  
Cases 
 
29 hospitals 
 
Cardiac 
hip/knee 
TAH 
 
 
Surgical site Infection risk 
increased as the time 
interval between dose 
and incision increased 
 
OR 1.74, 95%CI 0.98- 
3.04 
 
 
Not statistically 
significant (p = 0.04) 
 
Clinically significant 
 
Limited statistical 
power 2/2 low 
number of (+) cases. 
 
Post-discharge 
surveillance not 
standardized 
 
Truncated follow-up 
(due to parent 
study)...under 
ascertainment 
(lowered power)  
 
Vanco observations 
too low. 
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# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
11 Patrick 2010 II* 
 
Prospective 
RCT 
 
Single center 
18yo or > 
 
Vascular surgery 
 
N = 169 
 
Adding anti-MRSA 
prophylaxis does not 
Reduce the incidence of 
MRSA infection in low-
risk patients 
 
Groin procedures were 
3x as likely to acquire  
infection (p = .0282) 
 
Groin procedures were 
associated with longer 
surgical times and higher 
intraoperative glucose (p 
= .0007) 
66% power 
 
No standardized 
skin 
decontamination 
 
Dressing 
use/removal not  
standardized 
 
High-risk patients 
Excluded 
 
12 Salkind 2011 Review Article 5 articles with 
class A evidence 
(Timing)  
 
4 articles with 
class B evidence 
(consistent with 
guidelines/discont
inued within 24hrs 
Review of evidence for 
timing of antibx therapy, 
when to discontinue use, 
and published guidelines 
(SCIP measures) 
SCIP is falling out of 
favor 
 
Limited amount of 
identified evidence 
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# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
13 Tatterton 2011 Review Article  Review of evidence and 
reports to describe the 
incidence and type of 
infections that occur in 
the vascular surgery 
population 
Not scientific 
14 Bratzler 2013 Clinical Practice 
Guidelines 
 
American 
Society of 
Health-Care 
Pharmacists 
Multi-
organizational 
collaborative 
panel of experts 
 
Primary literature 
published 
between 1999-
2010 via 
MEDLINE, 
EMBASE, and 
Cochrane 
Database of 
Systematic 
Reviews. 
 
 
 
Graded recommendation 
based on strength of 
evidence (I-VII) 
 
Stratification between 
different surgical 
procedures, i.e. specific 
recommendations for 
specific types of surgery 
Limitation of 
available literature 
on antimicrobial 
prophylaxis 
 
Difficulty in 
establishing 
significant 
differences in 
efficacy among 
antimicrobial 
agents. 
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# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
14 Hawn 2013 IV* 
Retrospective 
Cohort study 
32,459 cases 
 
Orhtopedic 
Colorectal 
Vascular 
Gynecologic 
 
VA patient 
population 
 
Higher SSI rates w/ 
administration >60min 
prior to incision 
(OR 1.34, 95%CI 1.08-
1.66) 
 
Significant relationship 
between timing and SSI 
(p = .003) 
 
Mostly male 
patients 
 
Not capture of 
intraoperative 
redosing 
 
Small group of non-
timely 
administration 
 
16 Van der Slegt 2013 IV* 
Prospective 
Quasi 
experimental 
Cohort study 
720 vascular cases 
 
Continuous 
sample (3/2009-
1/2010) 
Bundle implementation 
 
Bundle compliance from 
10% to 80% 
Use of bundle reduced 
SSI (33% reduction)  
Lack of direct causal 
relationship (no 
randomized control) 
No performance of 
interrupted time 
series analysis 
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# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
17 Anderson 2014 I* 
Systematic 
Review 
Practice 
Recommendation  
 
 
 
 
 
 
 
 
Society for 
Healthcare 
Epidemiology of 
America 
 
Infectious Disease 
Society of America 
(relevant): administer 
antibx prophylaxis  
according to EB  
standards and guidelines 
(LEVEL I) 
 
Administer with 1hr (2 
hours allowed for vanc 
and flouroquinolones) 
 
Administer prior to 
tournequet  
 
Vanco 15mg/kg 
 
Not vascular specific 
 
 
 
 
 
 
 
 
18 Dua 2014 VI* 
 
Retrospective 
analysis 
National Inpatient 
Sample (NIS)-
largest all-payer 
inpatient 
database  
 
Stratified 20% 
No improvement in rate 
of SSI when SCIP 
measures implemented 
 
Increase in SSI rate with 
open AAAs 
 
Retrospective 
design 
 
Use of national 
database compiled 
by ICD-9 codes 
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# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
random sample of 
all nonfederal 
inpatient 
admissions 
 
2000-2010  
Stratified by ICD-9 
classification  
Use of SCIP measures 
may not be achieving 
what was intended with 
prophylactic 
antimicrobial dosing 
 
 
Only analyzed 
inpatients, no long 
term follow up data, 
potentially 
underreporting SSI 
rates. 
 
19 Sutherland 2014 Process 
Improvement 
Measure to 
improve SCIP 
compliance 
 
Descriptive 
 
Single center 
Descriptive report on 
implementation of 
methods to surveil and 
adhere to SCIP inf 1,2,3 
in a large academic 
institution 
 
Hundreds of thousands 
of dollars in cost savings 
Not scientific 
 
No other limitations 
20 Waits 2014 IV* 
Retrospective 
Cohort study  
Data from 24 
hospitals in MI 
 
4,085 colorectal 
surgeries analyzed 
between 2008-
Multisite sampling (more 
generalizable than 
previous similar studies) 
 
Large sample size 
 
Difficulty in 
inclusion of 
urgent/emergent 
surgeries 
(numerous 
incidents) may have 
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# First Author Year Level of 
Evidence 
Sample 
Composition 
Results Limitations 
2011. Single surgical population 
(with exception) 
led to selection bias 
 
Baseline education 
of clinicians not 
assessed 
21 Stone 2015 II* 
Prospective 
double-blind 
randomized 
controlled trial 
Adults undergoing 
groin or lower 
extremity vascular 
procedure 
 
N = 200 
Randomization 
 
Use of Cohen’s delta 
coefficient 3, due to 
impaired adequacy of 
endpoint SSI evaluation 
in both groups 
Single center 
 
No multivariate 
analysis to assess 
confounders 
 
*Melnyk Levels of Evidence: Melnyk, B.M. & Fineout-Overholt, E. (2015) Evidence-based practice in nursing & healthcare: A guide to best 
 practice (3rd ed.). Philadelphia, PA : Wolters Kluwer Health 
 
 
42 
 
Appendix B 
Education Tool 
 
 
ANTIMICROBIAL PROPHYLAXIS IN VASCULAR SURGERY 43 
 
 
  
ANTIMICROBIAL PROPHYLAXIS IN VASCULAR SURGERY 44 
 
Appendix C 
Data Collection Tool 
Date: Patient Weight (Kg): 
BMI: 
Patient Age: 
DOS: Surgery: 
 
 
 
 YES NO  
ESRD    
Hemodialysis    
Peritoneal Dialysis    
    
    
DM1   HgA1C: 
DM2   HgA1C: 
Smoking History   Pack year: 
    
Serious PCN/Cephalosporin Allergy   Rxn: 
Planned Infra-aortic graft implantation    
Known MRSA colonization    
Known MSSA colonization    
Antibiotic Vancomycin    
Antibiotic Cefazolin    
Antibiotic Other   Type: 
Antibiotic Start Time   ________:_________ 
Antibiotic Completed Time   ________:_________ 
Pre-Incision “time-out” Time   ________:_________ 
Surgical Incision Time   ________:_________ 
Time from Antibiotic Complete to Skin Incision   Min: 
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Incision Prior to Completed Antibiotic Admin.    
    
Appropriately Selected Antibiotic    
Appropriately Administered Antibiotic    
Appropriate Weight Based Antibiotic Dosage    
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Appendix D 
 
Vascular Surgery Clinical Practice Questionnaire 
            Date:____________________________ 
                                          Clinician Role:__________________________ 
 
 
Strongly 
Disagree 
Disagree 
Neither 
Disagree 
or Agree 
Agree 
Strongly 
Agree 
1. Antimicrobial prophylaxis for patients 
undergoing open vascular surgery is 
consistent with best practice. 
 
1 2 3 4 5 
2. Antimicrobial prophylaxis does not 
contribute to reductions in vascular surgical 
site infection. 
 
1 2 3 4 5 
3. I am confident in selecting the correct 
antimicrobial prophylaxis for vascular 
surgery. 
 
1 2 3 4 5 
4. I am able to identify a serious adverse 
reaction to PCN or cephalorsporin. 
 
1 2 3 4 5 
5. I am able to identify whether or not a 
prosthetic graft will be implanted prior to 
surgery. 
 
1 2 3 4 5 
6. I am able to identify whether or not a 
patient has a history of MRSA/MSSA 
colonization. 
 
1 2 3 4 5 
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Strongly 
Disagree 
Disagree 
Neither 
Disagree 
or Agree 
Agree 
Strongly 
Agree 
7. I am able to identify whether or not a 
patient has increase risk for MRSA/MSSA 
colonization. 
 
1 2 3 4 5 
8. The institution where I practice is 
considered to have a high prevalence of 
MRSA/MSSA. 
 
1 2 3 4 5 
9. It is best practice to administer the 
antimicrobial prophylaxis prior to surgical 
incision. 
 
1 2 3 4 5 
10. Patients with known MRSA/MSSA 
colonization should always receive 
vancomycin antimicrobial prophylaxis (if 
not allergic to vancomycin) 
 
1 2 3 4 5 
11. Patients scheduled for infra-inguinal 
prosthetic graft implantation should 
receive vancomycin antimicrobial 
prophylaxis (if not allergic to vancomycin). 
 
1 2 3 4 5 
12. Patients with serious adverse reactions to 
penicillin/cephalosporins should receive 
vancomycin antimicrobial prophylaxis (if 
not allergic to vancomycin). 
 
 
 
 
1 2 3 4 5 
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Strongly 
Disagree 
Disagree 
Neither 
Disagree 
or Agree 
Agree 
Strongly 
Agree 
13. If a patient has serious allergic reactions to 
cephalosporins AND vancomycin, I am 
confident in determining the best 
antimicrobial prophylaxis for vascular 
surgery procedures. 
 
1 2 3 4 5 
14. Overall, our antimicrobial prophylaxis 
selection is adherent to current clinical 
guidelines for vascular surgery. 
 
1 2 3 4 5 
15. Overall, antimicrobial prophylaxis 
administration is adherent to current 
clinical guidelines for vascular surgery. 
 
1 2 3 4 5 
 
